< 2004 News Listings Rho Ventures V Closes $425 Million Venture Fund NEW YORK, NY December 7, 2004 Rho Ventures today announced the final closing of Rho Ventures V, L.P. with commitments of $425 million. The fund will finance companies seeking early through expansion stage funding in a broad range of sectors including communications, healthcare and information technology. Rho has been an active participant in the U.S. venture capital sector since its inception in 1981. Venture capital funds under management currently exceed $1 billion. Rho Ventures IV, its prior fund, had its final closing in 2001 with $435 million in capital commitments. Rho Ventures has invested in over 150 venture stage companies and helped build market leaders across many high growth industries. Previous investments include Active Power, Capstone Turbine, Ciena Corporation, Commerce One, Compaq Computer Corporation, Copper Mountain, Inc., Diversa Corporation, Human Genome Sciences, Inc., iVillage, Leukosite (currently part of Millenium Pharmaceuticals), MedImmune, Inc., NitroMed, Senomyx, Tercica, Tripod (currently part of Lycos) and Vicuron. More information on Rho can be found at www.rho.com.
	Copyright ©2007 Rho Capital Partners, Inc.